Weight fell 9.6 lb
206.0 → 196.3 lbtypical before vs the latest three weeks
Guides · A diary drawn from a real record, rebuilt every night. Figures as of Nov 6, 2026.
A diary · Tesamorelin after growth hormone · since Sep 3, 2026
9 weeks after switching from growth hormone to tesamorelin
Rowan is a real person who keeps their health record in Selfsense. Rowan is not their name. This page is drawn from that record and rebuilds itself every night, so what follows is whatever the record says today, including the parts that did not go the way anyone would want.
The switch
Rowan took growth hormone (somatropin) from September 2020, 0.6 mg a day, for 6 years, and stopped on Sep 3, 2026. Tesamorelin started the same day, 1 mg a day.
Before that, Rowan tried tesamorelin for 13 days in July 2026 at 0.4 mg a day, alongside growth hormone. Those days fall inside the eight weeks the “before” figures come from.
A guided read
What moved, and when?
Each line is the typical reading of each week from one device. The lane on top is the drug, with a pin at every dose step and the dose written on the bar; growth hormone runs on the lane under it, up to the switch; the pins on the last lane are the days anything else in the regimen changed. Pick a card and its measure stays lit, with the typical week of the eight on growth hormone before the switch and the latest three weeks drawn as level lines; pick it again and the drawing is plain.
- weeks on it
- 9
- dose step
- 1
- measures read
- 6
The story4 cards · pick one, or walk through them below
Body fat fell 1.4 points
29.4 → 28.0%typical before vs the latest three weeks
Muscle mass fell 2.4 lb
79.4 → 77.1 lbtypical before vs the latest three weeks
Deep sleep rose 13 min
64 → 77 mintypical before vs the latest three weeks
the plain diary
Evidence for this story
Jun 8Jul 27Sep 14Nov 2
Tesamorelin
0.4 mg1 mg
Growth hormone
0.6 mg
Other changes
What the record shows
Weightlb194 – 212
Body fat%28 – 30
Muscle masslb77 – 81
Deep sleepmin50 – 106
Resting heart ratebpm61 – 77
Heart rate variability (Garmin)ms17 – 29
How to read the diary3 lanes · 6 measures · 22 weeks
TesamorelinrunningGrowth hormonebefore the switchOther changesstarted, stopped, changed dosea dose step, or another regimen changea measure, the typical reading of each week
Also drawn, without a card of its own: Resting heart rate fell 7 bpm, 75 → 68 bpm; Heart rate variability (Garmin): no real change, 22 → 25 ms.
“Before” is the typical week of the eight on growth hormone before the switch; “now” is the typical of the latest three on tesamorelin. A movement inside the measure’s normal week-to-week wobble is called no real change.
IGF-1, the number both are judged by
Growth hormone works largely through IGF-1, a hormone the liver makes in response to it, and IGF-1 is the blood test a prescriber watches on either drug. Tesamorelin asks the body to make more of its own growth hormone instead of supplying it, so the question for a switch is whether IGF-1 holds.
| Drawn | IGF-1 | The lab's range | Taking |
|---|---|---|---|
| Jul 17, 2020 | 109 ng/mL | 53–331 | before growth hormone |
| Sep 1, 2026 | 273 ng/mL | 52–328 | on growth hormone, just before the switch |
No draw since the switch yet. This page adds one the night it reaches the record, and the comparison above is the one it will be read against.
What else changed
Since the switch, Rowan's regimen changed on 4 other days: other supplements and medications started, stopped or changed dose. They are the pins on the “Other changes” lane of the drawing. This page does not name them, and it cannot separate them: no line here is tesamorelin alone.
Weight was coming down across this stretch (9.6 lb between “before” and now), and a change in weight on its own moves resting heart rate, heart rate variability, body fat and muscle. So the lines above are the switch and the weight change together, and this page cannot say how much of each.
Every week, as numbers · 22 weeks
| Week of | Body fat (%) | Muscle mass (lb) | Deep sleep (min) | Resting heart rate (bpm) | Heart rate variability (Garmin) (ms) | Weight (lb) |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | 30.4 | 80.6 | 106 | 61 | 21 | 210.9 |
| Jun 15, 2026 | 29.8 | 79.9 | 50 | 66 | 27 | 208.0 |
| Jun 22, 2026 | 29.8 | — | 58 | 68 | 28 | — |
| Jun 29, 2026 | 30.1 | 80.4 | 84 | 69 | 19 | 209.9 |
| Jul 6, 2026 | 29.7 | 80.8 | 83 | 73 | 21 | 211.5 |
| Jul 13, 2026 | 30.2 | 79.8 | 65 | 76 | 23 | 207.7 |
| Jul 20, 2026 | 29.5 | 79.6 | 60 | 75 | 18 | 206.6 |
| Jul 27, 2026 | 28.5 | 79.3 | 78 | 71 | 25 | 205.7 |
| Aug 3, 2026 | 29.5 | 79.3 | 59 | 75 | 24 | 205.7 |
| Aug 10, 2026 | 29.0 | 79.3 | 63 | 74 | 26 | 205.4 |
| Aug 17, 2026 | 29.4 | 79.5 | 59 | 76 | 18 | 206.2 |
| Aug 24, 2026 | 29.0 | 79.3 | 66 | 77 | 17 | 205.6 |
| Aug 31, 2026 | 28.9 | 79.3 | 62 | 73 | 27 | 205.4 |
| Sep 7, 2026 | 29.3 | 78.8 | 66 | 70 | 23 | 202.5 |
| Sep 14, 2026 | 29.2 | 78.7 | 80 | 75 | 24 | 203.1 |
| Sep 21, 2026 | 28.9 | 78.6 | 79 | 75 | 18 | 202.5 |
| Sep 28, 2026 | 29.0 | 77.9 | 62 | 70 | 28 | 199.7 |
| Oct 5, 2026 | 28.5 | 77.6 | 65 | 66 | 27 | 198.5 |
| Oct 12, 2026 | 28.3 | 77.6 | 80 | 68 | 29 | 198.8 |
| Oct 19, 2026 | 28.0 | 77.1 | 60 | 63 | 25 | 196.3 |
| Oct 26, 2026 | 27.6 | 76.5 | 77 | 68 | 25 | 194.1 |
| Nov 2, 2026 | 28.0 | 77.2 | 77 | 72 | 17 | 197.1 |
How this page is made
Every night Selfsense rebuilds a snapshot of this diary from Rowan’s record: the weekly typical of each measure from one device per measure, the dates and doses of both drugs, every IGF-1 draw, and the dates of other changes. The page reads only that snapshot, and the record itself is never public. Every sentence about the numbers is worked out by code from the numbers themselves; no AI reads the record to write them.
This is what Selfsense does with your own record, privately: every change on the same line as the measures and labs that moved after it. Start yours.
One person’s record, not medical advice, and not a recommendation of any treatment. One person’s numbers say nothing about what will happen to you. Prescribing decisions belong to you and a licensed healthcare professional.